المؤلفون: Abdelmogod, A, Papadopoulos, L, Riordan, S, Wong, M, Weltman, M, Lim, R, Mcevoy, C, Fellowes, A, Fox, S, Bedo, J, Penington, J, Pham, K, Hofmann, O, Vissers, JHA, Grimmond, S, Ratnayake, G, Christie, M, Mitchell, C, Murray, WK, Mcclymont, K, Luk, P, Papenfuss, AT, Kee, D, Scott, CL, Goldstein, D, Barker, HE

العلاقة: NHMRC/1081178; NHMRC/1062702; pii: cancers15174378; Abdelmogod, A., Papadopoulos, L., Riordan, S., Wong, M., Weltman, M., Lim, R., Mcevoy, C., Fellowes, A., Fox, S., Bedo, J., Penington, J., Pham, K., Hofmann, O., Vissers, J. H. A., Grimmond, S., Ratnayake, G., Christie, M., Mitchell, C., Murray, W. K. ,. Barker, H. E. (2023). A Matched Molecular and Clinical Analysis of the Epithelioid Haemangioendothelioma Cohort in the Stafford Fox Rare Cancer Program and Contextual Literature Review. CANCERS, 15 (17), https://doi.org/10.3390/cancers15174378Test.; http://hdl.handle.net/11343/339230Test

الإتاحة: https://doi.org/10.3390/cancers15174378Test
http://hdl.handle.net/11343/339230Test

المؤلفون: Ho, GY, Vandenberg, CJ, Lim, R, Christie, EL, Garsed, DW, Lieschke, E, Nesic, K, Kondrashova, O, Ratnayake, G, Radke, M, Penington, JS, Carmagnac, A, Heong, V, Kyran, EL, Zhang, F, Traficante, N, Huang, R, Dobrovic, A, Swisher, EM, McNally, O, Kee, D, Wakefield, MJ, Papenfuss, AT, Bowtell, DDL, Barker, HE, Scott, CL

العلاقة: NHMRC/400281; NHMRC/400413; NHMRC/1081178; pii: 10.1177_17588359231208674; Ho, G. Y., Vandenberg, C. J., Lim, R., Christie, E. L., Garsed, D. W., Lieschke, E., Nesic, K., Kondrashova, O., Ratnayake, G., Radke, M., Penington, J. S., Carmagnac, A., Heong, V., Kyran, E. L., Zhang, F., Traficante, N., Huang, R., Dobrovic, A., Swisher, E. M. ,. Scott, C. L. (2023). The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 15, https://doi.org/10.1177/17588359231208674Test.; http://hdl.handle.net/11343/344499Test

الإتاحة: https://doi.org/10.1177/17588359231208674Test
http://hdl.handle.net/11343/344499Test

المؤلفون: Coleman, Robert L, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew, Scambia, Giovanni, Leary, Alexandra, Holloway, Robert W, Gancedo, Margarita Amenedo, Fong, Peter C, Goh, Jeffrey C, O'Malley, David M, Armstrong, Deborah K, Garcia-Donas, Jesus, Swisher, Elizabeth M, Floquet, Anne, Konecny, Gottfried E, McNeish, Iain A, Scott, Clare L, Cameron, Terri, Maloney, Lara, Isaacson, Jeff, Goble, Sandra, Grace, Caroline, Harding, Thomas C, Raponi, Mitch, Sun, James, Lin, Kevin K, Giordano, Heidi, Ledermann, Jonathan A, investigators, ARIEL3, Buck, M, Dean, A, Friedlander, ML, Goh, JC, Harnett, P, Kichenadasse, G, Scott, CL, Denys, H, Dirix, L, Vergote, I, Elit, L, Ghatage, P, Oza, AM, Plante, M, Provencher, D, Weberpals, JI, Welch, S, Floquet, A, Gladieff, L, Joly, F, Leary, A, Lortholary, A, Lotz, J, Medioni, J, Tredan, O, You, B, El-Balat, A, Hänle, C, Krabisch, P, Neunhöffer, T, Pölcher, M, Wimberger, P, Amit, A, Kovel, S, Leviov, M, Safra, T, Shapira-Frommer, R, Stemmer, S, Bologna, A, Colombo, N, Lorusso, D, Pignata, S, Sabbatini, RF, Scambia, G, Tamberi, S, Zamagni, C, Fong, PC, O'Donnell, A, Gancedo, M Amenedo, Herraez, A Casado, Garcia-Donas, J, Guerra, EM, Oaknin, A, Palacio, I, Romero, I, Sanchez, A, Banerjee, SN, Clamp, A, Drew, Y, Gabra, HG, Jackson, D, Ledermann, JA, McNeish, IA, Parkinson, C, Powell, M

المصدر: The Lancet. 390(10106)

مصطلحات موضوعية: Reproductive Medicine, Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Orphan Drug, Clinical Research, Cancer, Genetics, Clinical Trials and Supportive Activities, Ovarian Cancer, Rare Diseases, Evaluation of treatments and therapeutic interventions, 6.1 Pharmaceuticals, 6.2 Cellular and gene therapies, Aged, Disease-Free Survival, Double-Blind Method, Female, Follow-Up Studies, Humans, Indoles, Internationality, Maintenance Chemotherapy, Middle Aged, Molecular Targeted Therapy, Neoplasm Recurrence, Local, Ovarian Neoplasms, Poly(ADP-ribose) Polymerase Inhibitors, Risk Assessment, Survival Rate, Treatment Outcome, ARIEL3 investigators, Medical and Health Sciences, General & Internal Medicine, Biomedical and clinical sciences, Health sciences

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/9xn4w6v7Test

المؤلفون: Gao, J, Jung, M, Williams, RT, Hui, D, Russell, AJ, Naim, AJ, Kamili, A, Clifton, M, Bongers, A, Mayoh, C, Ho, G, Scott, CL, Jessup, W, Haber, M, Norris, MD, Henderson, MJ

المصدر: urn:ISSN:2072-6694 ; Cancers, 14, 8, 1878

مصطلحات موضوعية: Rare Diseases, Ovarian Cancer, Cancer, Orphan Drug, 5.1 Pharmaceuticals, 5 Development of treatments and therapeutic interventions, 2 Aetiology, 2.1 Biological and endogenous factors, ABCA1, cholesterol, epithelial ovarian cancer, anzsrc-for: 1112 Oncology and Carcinogenesis

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/1959.4/unsworks_80925Test; https://unsworks.unsw.edu.au/bitstreams/24d7f4db-1710-4cb4-84df-bc8e9232d225/downloadTest; https://doi.org/10.3390/cancers14081878Test

الإتاحة: https://doi.org/10.3390/cancers14081878Test
http://hdl.handle.net/1959.4/unsworks_80925Test
https://unsworks.unsw.edu.au/bitstreams/24d7f4db-1710-4cb4-84df-bc8e9232d225/downloadTest

المؤلفون: Meagher, NS, Gorringe, KL, Wakefield, M, Bolithon, A, Pang, CNI, Chiu, DS, Anglesio, MS, Mallitt, K-A, Doherty, JA, Harris, HR, Schildkraut, JM, Berchuck, A, Cushing-Haugen, KL, Chezar, K, Chou, A, Tan, A, Alsop, J, Barlow, E, Beckmann, MW, Boros, J, Bowtell, DDL, Brand, AH, Brenton, JD, Campbell, I, Cheasley, D, Cohen, J, Cybulski, C, Elishaev, E, Erber, R, Farrell, R, Fischer, A, Fu, Z, Gilks, B, Gill, AJ, Gourley, C, Grube, M, Harnett, PR, Hartmann, A, Hettiaratchi, A, Hogdall, CK, Huzarski, T, Jakubowska, A, Jimenez-Linan, M, Kennedy, CJ, Kim, B-G, Kim, J-W, Kim, J-H, Klett, K, Koziak, JM, Lai, T, Laslavic, A, Lester, J, Leung, Y, Li, N, Liauw, W, Lim, BWX, Linder, A, Lubinski, J, Mahale, S, Mateoiu, C, McInerny, S, Menkiszak, J, Minoo, P, Mittelstadt, S, Morris, D, Orsulic, S, Park, S-Y, Pearce, CL, Pearson, J, Pike, MC, Quinn, CM, Mohan, GR, Rao, J, Riggan, MJ, Ruebner, M, Salfinger, S, Scott, CL, Shah, M, Steed, H, Stewart, CJR, Subramanian, D, Sung, S, Tang, K, Timpson, P, Ward, RL, Wiedenhoefer, R, Thorne, H, Cohen, PA, Crowe, P, Fasching, PA, Gronwald, J, Hawkins, NJ, Hogdall, E, Huntsman, DG, James, PA, Karlan, BY, Kelemen, LE, Kommoss, S, Konecny, GE, Modugno, F, Park, SK, Staebler, A, Sundfeldt, K, Wu, AH, Talhouk, A, Pharoah, PDP, Anderson, L, DeFazio, A, Kobel, M, Friedlander, ML, Ramus, SJ

العلاقة: NHMRC/1092856; NHMRC/310670; NHMRC/400281; NHMRC/1023698; NHMRC/628903; NHMRC/400413; NHMRC/1117044; pii: 709665; Meagher, N. S., Gorringe, K. L., Wakefield, M., Bolithon, A., Pang, C. N. I., Chiu, D. S., Anglesio, M. S., Mallitt, K. -A., Doherty, J. A., Harris, H. R., Schildkraut, J. M., Berchuck, A., Cushing-Haugen, K. L., Chezar, K., Chou, A., Tan, A., Alsop, J., Barlow, E., Beckmann, M. W. ,. Ramus, S. J. (2022). Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes. CLINICAL CANCER RESEARCH, 28 (24), pp.5383-5395. https://doi.org/10.1158/1078-0432.CCR-22-1206Test.; http://hdl.handle.net/11343/320060Test

الإتاحة: https://doi.org/10.1158/1078-0432.CCR-22-1206Test
http://hdl.handle.net/11343/320060Test

المؤلفون: Cremona, M, Vandenberg, CJ, Farrelly, AM, Madden, SF, Morgan, C, Kalachand, R, McAlpine, JN, Toomey, S, Huntsman, DG, Grogan, L, Breathnach, O, Morris, P, Carey, MS, Scott, CL, Hennessy, BT

العلاقة: pii: 10.1038/s41416-022-01823-5; Cremona, M., Vandenberg, C. J., Farrelly, A. M., Madden, S. F., Morgan, C., Kalachand, R., McAlpine, J. N., Toomey, S., Huntsman, D. G., Grogan, L., Breathnach, O., Morris, P., Carey, M. S., Scott, C. L. & Hennessy, B. T. (2022). BRCA mutations lead to XIAP overexpression and sensitise ovarian cancer to inhibitor of apoptosis (IAP) family inhibitors. BRITISH JOURNAL OF CANCER, 127 (3), pp.488-499. https://doi.org/10.1038/s41416-022-01823-5Test.; http://hdl.handle.net/11343/309090Test

الإتاحة: https://doi.org/10.1038/s41416-022-01823-5Test
http://hdl.handle.net/11343/309090Test

المؤلفون: Bound, NT, Vandenberg, CJ, Kartikasari, AER, Plebanski, M, Scott, CL

العلاقة: pii: 886170; Bound, N. T., Vandenberg, C. J., Kartikasari, A. E. R., Plebanski, M. & Scott, C. L. (2022). Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system. FRONTIERS IN GENETICS, 13, https://doi.org/10.3389/fgene.2022.886170Test.; http://hdl.handle.net/11343/322162Test

الإتاحة: https://doi.org/10.3389/fgene.2022.886170Test
http://hdl.handle.net/11343/322162Test

المؤلفون: Ho, GY, Kyran, EL, Bedo, J, Wakefield, MJ, Ennis, DP, Mirza, HB, Vandenberg, CJ, Lieschke, E, Farrell, A, Hadla, A, Lim, R, Dall, G, Vince, JE, Chua, NK, Kondrashova, O, Upstill-Goddard, R, Bailey, U-M, Dowson, S, Roxburgh, P, Glasspool, RM, Bryson, G, Biankin, AV, Cooke, SL, Ratnayake, G, McNally, O, Traficante, N, DeFazio, A, Weroha, SJ, Bowtell, DD, McNeish, IA, Papenfuss, AT, Scott, CL, Barker, HE

العلاقة: NHMRC/1081178; NHMRC/1062702; NHMRC/400281; NHMRC/400413; pii: 709667; Ho, G. Y., Kyran, E. L., Bedo, J., Wakefield, M. J., Ennis, D. P., Mirza, H. B., Vandenberg, C. J., Lieschke, E., Farrell, A., Hadla, A., Lim, R., Dall, G., Vince, J. E., Chua, N. K., Kondrashova, O., Upstill-Goddard, R., Bailey, U. -M., Dowson, S., Roxburgh, P. ,. Barker, H. E. (2022). Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin. CANCER RESEARCH, 82 (23), pp.4457-4473. https://doi.org/10.1158/0008-5472.CAN-21-4012Test.; http://hdl.handle.net/11343/320081Test

الإتاحة: https://doi.org/10.1158/0008-5472.CAN-21-4012Test
http://hdl.handle.net/11343/320081Test

المؤلفون: Kok, P-S, Antill, YC, Scott, CL, Lee, CK

العلاقة: pii: S2059-7029(22)00269-1; Kok, P. -S., Antill, Y. C., Scott, C. L. & Lee, C. K. (2022). The impact of single agent PD-1 or PD-L1 inhibition on advanced endometrial cancers: meta-analysis. ESMO OPEN, 7 (6), https://doi.org/10.1016/j.esmoop.2022.100635Test.; http://hdl.handle.net/11343/334541Test

الإتاحة: https://doi.org/10.1016/j.esmoop.2022.100635Test
http://hdl.handle.net/11343/334541Test

المؤلفون: Grohmann, C, Walker, F, Devlin, M, Luo, MX, Chüeh, AC, Doherty, J, Vaillant, F, Ho, GY, Wakefield, MJ, Weeden, CE, Kamili, A, Murray, J, Po’uha, ST, Weinstock, J, Kane, SR, Faux, MC, Broekhuizen, E, Zheng, Y, Shield-Artin, K, Kershaw, NJ, Tan, CW, Witchard, HM, Ebert, G, Charman, SA, Street, I, Kavallaris, M, Haber, M, Fletcher, JI, Asselin-Labat, ML, Scott, CL, Visvader, JE, Lindeman, GJ, Watson, KG, Burgess, AW, Lessene, G

المصدر: urn:ISSN:2041-4889 ; Cell Death and Disease, 12, 3, 268

مصطلحات موضوعية: Rare Diseases, Biotechnology, Orphan Drug, Lung Cancer, Neurosciences, Ovarian Cancer, Neuroblastoma, Cancer, Breast Cancer, Genetics, Lung, 5 Development of treatments and therapeutic interventions, 5.1 Pharmaceuticals, Animals, Antimitotic Agents, Apoptosis, Cell Proliferation, Drug Resistance, Neoplasm, Female, G2 Phase Cell Cycle Checkpoints, Hep G2 Cells, Humans, Mice, Inbred BALB C, Inbred C57BL, Nude, Mitosis, Neoplasms, PC-3 Cells

وصف الملف: application/pdf

العلاقة: http://purl.org/au-research/grants/nhmrc/APP1119152Test; http://hdl.handle.net/1959.4/unsworks_76233Test; https://unsworks.unsw.edu.au/bitstreams/8e5191f0-886b-4b2d-984c-dbe15394dcd8/downloadTest; https://doi.org/10.1038/s41419-020-03269-0Test

الإتاحة: https://doi.org/10.1038/s41419-020-03269-0Test
http://hdl.handle.net/1959.4/unsworks_76233Test
https://unsworks.unsw.edu.au/bitstreams/8e5191f0-886b-4b2d-984c-dbe15394dcd8/downloadTest